获得性囊性肾病相关性肾细胞癌伴破裂出血及尿漏1例

doi:10.3760/cma.j.issn.1007-1245.2024.04.024

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (4): 634-637.DOI: 10.3760/cma.j.issn.1007-1245.2024.04.024

获得性囊性肾病相关性肾细胞癌伴破裂出血及尿漏1例

唐燕王丽娟侯国旗李英明

青岛大学附属威海市中心医院病理科，威海　264400

收稿日期:2023-07-21 出版日期:2024-02-01 发布日期:2024-03-07
通讯作者: 李英明，Email：liyingming1973@sina.com

One case of acquired cystic kidney disease-associated renal cell carcinoma with ruptured bleeding and urinary leakage

Tang Yan, Wang Lijuan, Hou Guoqi, Li Yingming

Department of Pathology, Weihai Central Hospital Affiliated to Qingdao University, Weihai 264400, China

Received:2023-07-21 Online:2024-02-01 Published:2024-03-07
Contact: Li Yingming, Email: liyingming1973@sina.com

摘要/Abstract

摘要：

获得性囊性肾病相关性肾细胞癌（ACKD-RCC）是发生于获得性囊性肾病患者最常见的肾细胞癌类型。鉴于该肿瘤组织病理学独特，2016版世界卫生组织（WHO）肾脏肿瘤分类将其列为新增的肾细胞癌亚型之一。目前，关于该肿瘤的报道较少且多为个案报道，本文报道1例ACKD-RCC，通过查阅相关文献分析总结其临床病理学特征，旨在提高对该少见肾细胞癌亚型的认识。

关键词:

肾细胞癌, 获得性囊性肾病, 破裂, 病理

Abstract:

Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) is the most common type of renal cell carcinoma that occurs in patients with acquired cystic kidney disease. Due to the unique histopathology of this tumor, it is listed as one of the newly added renal cell carcinoma subtypes in the 2016 edition of the WHO Classification of Renal Tumors. At present, there are few reports on this tumor and most of them are case reports. This paper reports a case of ACKD-RCC, and summarizes its clinicopathological features by referring to relevant literatures, in order to improve the understanding on this rare subtype of renal cell carcinoma.

Key words:

Renal cell carcinoma, , Acquired cystic kidney disease, Rupture, Pathology

唐燕王丽娟侯国旗李英明.

获得性囊性肾病相关性肾细胞癌伴破裂出血及尿漏1例 [J]. 国际医药卫生导报, 2024, 30(4): 634-637.

Tang Yan, Wang Lijuan, Hou Guoqi, Li Yingming.

One case of acquired cystic kidney disease-associated renal cell carcinoma with ruptured bleeding and urinary leakage [J]. International Medicine and Health Guidance News, 2024, 30(4): 634-637.

参考文献

[1] Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidnens: a hazard of long-term intermittent maintenance haemodialysis [J]. J Clin Pathol, 1977, 30(9):868-877. DOI: 10.1136/jcp.30.9.868.
[2] Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia [J]. Am J Surg Pathol, 2006, 30(2): 141-153. DOI: 10.1097/01.pas.0000185382. 80844.b1.
[3] Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs [M]. Lyon: IARC Press, 2016.
[4] 饶秋,夏秋媛,周晓军,等. 2016版 WHO 肾脏肿瘤新分类解读[J]. 中华病理学杂志,2016,45(7): 435-441. DOI: 10. 3760/cma.j.issn.0529-5807.2016.07.002.
[5] 施珍,金领微,高依依,等. 血液透析患者获得性肾囊肿的临床回顾分析[J]. 中国中西医结合肾病杂志,2014,15(1):46-47.
[6] Nouh MA, Kuroda N, Yamashita M, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis [J]. BJU Int, 2010, 105(5): 620-627. DOI: 10.1111/j.1464-410X.2009.08817.x.
[7] 杨建勋,付启忠,董圣芳,等. 获得性肾囊性疾病合并肾癌11例临床分析[J]. 中华泌尿外科杂志,2011,32(2):99-102. DOI:10.3760/cma.j.issn.1000-6702.2011.02.008.
[8] Rahbari-Oskoui F, O'Neill WC. Diagnosis and management of acquired cystic kidney disease and renal tumors in ESRD patients[J]. Semin Dial, 2017, 30(4): 373-379. DOI: 10.1111/sdi.12605.
[9] 张伟,徐丽丽,于文娟,等. 获得性囊性肾病相关性肾细胞癌临床病理学观察[J]. 中华病理学杂志,2018,47(5):366-371. DOI:10.3760/cma.j.issn.0529-5807.2018.05.010.
[10] Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study [J]. Am J Surg Pathol, 2005, 29(4): 443-451. DOI: 10.1097/01.pas.0000152131.58492.97.
[11] Ahn S, Kwon GY, Cho YM, et al. Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features[J]. Med Mol Morphol, 2013, 46(4): 225-232. DOI: 10.1007/s00795-013-0028-x.
[12] Inoue T, Matsuure K, Yoshimoto T, et al. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease[J]. Cancer Sci, 2012, 103(3): 569-576. DOI:10.1111/j.1349-7006.2011.02176.x.
[13] Kuroda N, Tamura M, Hamaguchi N, et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features[J]. Ann Diagn Pathol, 2011, 15(6): 462-466. DOI:10.1016/j.anndiagpath.2010.07.008.
[14] Bhatnagar R, Alexiev BA. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma [J]. Int J Surg Pathol, 2012, 20(1): 19-28. DOI: 10.1177/1066896911414273.
[15] Przybycin CG, Harper HL, Reynolds JP, et al. Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up [J]. Am J Surg Pathol, 2018, 42(9): 1156-1165. DOI: 10.1097/PAS.0000000000001091.
[16] 何冰,张伟,刘莉娜,等. 终末期肾病合并肾细胞癌的临床病理学特征[J]. 中华病理学杂志,2019,48(11):846-850. DOI:10.3760/cma.j.issn.0529?5807.2019.11.003.
[17] 赵媛,陈红,金木兰. 琥珀酸脱氢酶缺陷型肾癌1例并文献复习[J]. 临床与实验病理学杂志,2019,35(12):1472-1474. DOI:10.13315/j.cnki.cjcep.2019.12.021.
[18] Kondo T, Sassa N, Yamada H, et al. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study[J]. Pathology, 2021, 53(6): 720-727. DOI: 10.1016/j.pathol.2021.01.014.
[19] 谢红建,宋晓霞,赵跃武,等. 获得性囊性肾病相关性肾细胞癌一例[J].中国临床案例成果数据库,2022, 4(1): E02349-E02349. DOI:10.3760/cma.j.cmcr.2022.e02349.
[20] 陈恕求, 陈明, 张晓文, 等. 长期血透患者获得性囊性肾病合并肾癌8例报告并文献复习[J]. 临床泌尿外科杂志,2012,27(1):33-35. DOI:10.13201/j.issn.1001-1420.2012. 01.014.

获得性囊性肾病相关性肾细胞癌伴破裂出血及尿漏1例

One case of acquired cystic kidney disease-associated renal cell carcinoma with ruptured bleeding and urinary leakage

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	王丽君刘瑜马雪枫. 妊娠中期不典型子宫破裂误诊1例 [J]. 国际医药卫生导报, 2023, 29(9): 1290-1293.
[2]	尹金阁王栓铎. 生长抑素针联合三腔两囊管治疗肝硬化合并EGVB患者的效果 [J]. 国际医药卫生导报, 2023, 29(5): 655-659.
[3]	张小雪郭庆枝孙聪聪周超高学锋张英姿. 女性生殖系统同时性多原发癌2例报道并文献复习 [J]. 国际医药卫生导报, 2023, 29(3): 369-371.
[4]	赵昌乾谢丽张敏郭金红. 常规超声联合血清甲状腺球蛋白抗体水平对桥本甲状腺炎的诊断价值 [J]. 国际医药卫生导报, 2023, 29(24): 3571-3575.
[5]	张红红李涌. 甲状腺癌组织的CCL11、VEGF表达与病理特征的关系 [J]. 国际医药卫生导报, 2023, 29(18): 2566-2570.
[6]	丁佰娟张立伟杨慧崔秀娟李南. IGSF9在上皮性卵巢癌中的表达及对卵巢癌细胞转移能力的影响 [J]. 国际医药卫生导报, 2023, 29(16): 2268-2272.
[7]	严然郭春娜. 儿童肾穿刺35例临床及病理分析 [J]. 国际医药卫生导报, 2023, 29(10): 1421-1424.
[8]	臧晗伟杨丽娟杜昭启李伟. 主动脉瘤动物模型研究进展 [J]. 国际医药卫生导报, 2023, 29(1): 4-.
[9]	魏绪建, 臧丽芳, 程晓莉, 赵鹏. 经皮钛网骨水泥填充术治疗老年骨质疏松性椎体压缩性骨折的临床效果[J]. 国际医药卫生导报, 2022, 28(5): 637-641.
[10]	于文龙, 殷晓伟, 杨玉柱, 许艳梅. 巨大乳腺腺鳞癌1例并文献复习[J]. 国际医药卫生导报, 2022, 28(3): 419-421.
[11]	姜秋慧宋晓霞. lncRNA CCAT1在子宫内膜癌组织中的表达及其与病理参数的关系[J]. 国际医药卫生导报, 2022, 28(24): 3423-.
[12]	杨汉顾玉兰. 神经纤毛蛋白-1在胃癌组织中的表达与临床病理特征及预后相关性的meta分析[J]. 国际医药卫生导报, 2022, 28(22): 3246-3251.
[13]	唐学良张晖凌明强. 肝硬化食管静脉曲张破裂出血的临床特点与危险因素分析[J]. 国际医药卫生导报, 2022, 28(19): 2753-2757.
[14]	相龙全马廷廷王慧张孝常林凡忠张光海. 腮腺分泌性癌1例[J]. 国际医药卫生导报, 2022, 28(18): 2630-2634.
[15]	林小庆龚望球张静高霞邓会英杨华彬 . 单中心66例儿童IgA肾病肾脏病理Lee氏分级与临床特征的相关性分析[J]. 国际医药卫生导报, 2022, 28(16): 2295-2298.